Board Member
Reagan-Udall Foundation
Kay Holcombe recently retired as Senior Vice President for Science Policy at BIO, the Biotechnology Innovation Organization. Prior to that, she was Vice President for Government Relations at Sanofi-Genzyme; Executive Vice President of Policy Directions Inc., a policy advisory and advocacy firm; professional health legislative staff and senior health policy advisor for the House of Representatives Committee on Energy and Commerce; professional health legislative staff for the Senate Committee on Labor and Human Resources; Deputy Associate Commissioner for Legislative Affairs, U.S. Food and Drug Administration; Executive Vice President of the Foundation for Biomedical Research; Associate Director for Public Health Legislation, HHS Office of the Assistant Secretary for Legislation; Deputy Associate Administrator for Planning, Evaluation, and Legislation, Health Resources and Services Administration; Special Assistant to the Director, Division of Legislative Affairs, National Institutes of Health; Executive Secretary, National Heart, Lung, and Blood Institute National Advisory Council; and NHLBI researcher. Kay is a member of the board of the Reagan-Udall Foundation for the FDA, the National Blood Clot Alliance, and the Critical Path Institute. She received her B.S. in chemistry education from the University of Illinois and her M.S. in chemistry from the University of Virginia. She graduated with honors and was elected to Phi Beta Kappa, Phi Kappa Phi, and Iota Sigma Pi.
None yet.